|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Acumen Pharmaceuticals (NASDAQ: ABOS) through any online brokerage.
There are no as such competitors for Acumen Pharmaceuticals.
The latest price target for Acumen Pharmaceuticals (NASDAQ: ABOS) was reported by UBS on July 26, 2021. The analyst firm set a price target for 27.00 expecting ABOS to rise to within 12 months (a possible 81.21% upside). 4 analyst firms have reported ratings in the last year.
The stock price for Acumen Pharmaceuticals (NASDAQ: ABOS) is $14.9 last updated Wed Jul 28 2021 20:00:02 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Acumen Pharmaceuticals.
Acumen Pharmaceuticals does not have any upcoming earnings scheduled.
There is no upcoming split for Acumen Pharmaceuticals.
Acumen Pharmaceuticals is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.